What The Study Did: Researchers evaluated whether systemic anticancer treatments, tumor subtypes, patient demographic characteristics and comorbidities were associated with COVID-19 mortality among 2,500 adult patients with cancer and COVID-19.
Authors: Gary Middleton, M.D., of the University of Birmingham in Birmingham, United Kingdom, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2022.0130)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.0130?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=022122
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
JAMA Network Open